HIV-1 genomic RNA packaging is a highly specific process involving interactions between the viral Gag precursor and cis acting packaging signals in the 5' leader sequence of HIV-1 genomic RNA. We examined the suppression effect of HIV-1 expression by the decoy RNAs targeted to these HIV-1 transcriptional and packaging regulatory regions. HIV-1 expression was inhibited by the 5'-LTR decoy RNA, and measured by the amount of HTV-1 gag p24 protein, but no inhibition of HIV-1 packaging could be detected.
INTRODUCTION
Human immunodeficiency virus type 1 (HIV-1) gene therapy strategies have been based on antisense RNAs, ribozymes, and decoy RNAs (1) (2) (3) . Many of these strategies are aimed at inhibiting HIV-1 protein-RNA interactions between frans-activator of transcription. Antisense RNA and ribozyme strategies require sequence conservation of their RNA targets for continued activity, and therefore may not be susceptible to the viral escape resulting from the high mutation rate of HIV-1. By contrast, a decoy RNA is designed to interact specifically with a protein target. Hence, if there are no alterations in the protein coding sequence and the natural HTV-1 ligand, then in this way, decoy RNAs may represent a more versatile and long-lived antiviral strategy.
The HIV-1 Tat protein regulates transcription elongation through binding to the /ram-activation response (TAR) RNA stem-loop structure (4) . The overexpression of the TAR sequence was shown to inhibit HIV-1 replication (1).
An essential step during HIV-1 replication is the encapsidation of two full-length HIV-1 genomic RNAs. Selective encapsidation depends upon the recognition of HIV-1 RNA by the zinc finger-like motif in the nucleocapsid domain of PriS 0 " 8 (5). The HIV-1 packaging signal includes the dimer linkage structure (DLS). These regions are essential and sufficient for RNA packaging.
We now demonstrate the inhibition of HIV-1 products using the 5'LTR decoy RNA containing the DLS sequence to compete with viral RNAs in cultured cells. Inhibition of HIV-1 replication was assessed in transient transfection in the COS cell line. As a result, the 5'LTR decoy RNA containing the DLS sequence was shown to reduce HTV-1 p24 antigen production in the COS cells. However, this decoy RNA did not cause the inhibition of HIV-1 packaging. To overcome this problem, the 5'LTR decoy RNA containing the DLS sequence was added to the Rev-response element (RRE) sequence located within the env-coding region. The RRE sequence appears to increase the packaging efficiency.
However, this modified decoy RNA, which was localized in the cytoplasm of the COS cells, did not inhibit fflV-1 packaging.
RESULTS AND DISCUSSION
Construction of the Decoy RNA Expression Vectors. We cloned the decoy RNAs targeted against the H1V-1 5'-LTR into mammalian expression vectors downstream of the human cytomegalovirus immediate-early (CMV) promoter. For the construction of the LTR vector, an 800 bp fragment of the fflV-1 5'-LTR containing the DLS was ligated into the EcoRV fragment of pVAXl, and was amplified from pNL4-3 by polymerase chain reaction (PCR). The LTR-RRE vector was constructed by the insertion of the RRE sequence into the Apa I and Kpn I sites of the LTR vector.
Intracellular Localization of Decoy RNA.
The binding of the HIV-1 Rev protein to the RRE sequence facilitates the nuclear export of HIV-1 genomic RNA. To determine the cellular localization of the decoy RNA, COS cells transfected with the LTR or LTR-RRE vector in the presence or absence of pNL4-3 were analyzed by RT-PCR. The localization of the LTR decoy RNA in the cytoplasm and nucleus was similar in the presence or absence of pNL4-3, while the LTR-RRE decoy RNA was localized in the cytoplasm in the presence of pNL4-3.
Inhibition of HIV-1 Replication by Decoy RNAs in COS Cells
. COS cells were transfected with pNL4-3 and the decoy RNA expression vector. The culture supernatant was collected and measured for HIV-1 p24 antigen production. In COS cells transfected with LTR decoy RNA was reduced, HIV-1 p24 antigen production, and RRE-containing LTR decoy RNA was more effective than LTR decoy RNA on the anti-HIV-1 activity (Fig. 1) .
Inhibition of HIV-1 Packaging by Decoy RNAs in COS Cells.
The HIV-1 packaging efficiency was determined by an RT-PCR analysis. Viral RNA was extracted from purified viral particles harvested from transfected COS cells, and the amount of virus was standardized on the basis of the p24 antigen levels. Viral RNA was determined by RT-PCR amplification of a 528-nt RNA fragment within the gag region as a reflection of the packaging of full-length HIV-1 genomic RNA. The result indicated that the HTV-1 packaging inhibitory effect was not reduced in the COS cells transfected with either the LTR or LTR-RRE decoy RNA. cells/60-mm diameter dish, incubated for 1 day, and transfected with pNL4-3 (0.1 ug) and a decoy RNA expression vector (1.0 n g). After 2 days, the supernatant was collected. The level of the HIV-1 p24 antigen in each supernatant was determined by a chemiluminesent enzyme immunoassay (CLEIA).
